Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD

Stopped VTL-308 failed to meet its primary endpoint, all follow up studies were terminated

Conditions

• Acute Alcoholic Hepatitis

Interventions

• BIOLOGICAL: ELAD System
• OTHER: Standard of Care (Control)

Sponsor

Vital Therapies, Inc.